Carlos Guimarães is the CEO at Biocancer Clinical Research in Brazil. Biocancer is an oncology-focused drug development services company which assists pharmaceutical, biotechnology, medical device and drug development services companies in accessing Brazil's large patient populations. Since 2006, he is responsible for the general administration of the company, including its strategic realignment for venture capital investment.
Previously, Guimarães was the director of a successful Brazilian biotech company where he was responsible for national and international expansion. He has a broad international experience, a strong ability to lead teams, and exceptional performance in the commercial area. Over the last 10 years he has been running different business and since May 2006, was in charge of leading Biocancer to a distinguished position in clinical trials in the world.
Carlos Guimaraes graduated with a degree in Business Administration from Federal University of Minas Gerais (UFMG) Brazil, and received his MBA Executive International degree at Fundação Dom Cabral (Brazil & Sauder Business School (Canada).
A business plan is designed to be followed, hard as that may seem. We say: Let's design a business plan to get funding from a venture capitalist or Angel investor, and then see how we'll do. That's not the way to do it. Even though this is a recent, incipient market without a lot of information, ...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login